MedPath

Follow-up Study of COVID-19 Patients in the District Konstanz

Completed
Conditions
SARS-CoV-2 Positive Patients
Registration Number
NCT04724434
Lead Sponsor
Hegau-Bodensee-Klinikum Singen
Brief Summary

This is a prospective single-center study for the follow-up of SARS-CoV-2 positive patients in the district of Konstanz (LKN). As part of the coronavirus pandemic, patients with SARS-CoV-2 infection are currently being treated in the clinics of the LKN's health network at the Singen (Hegau-Bodensee Clinic) and Konstanz (Konstanz Clinic) locations. So far, there is little data on the long-term effects of SARS-CoV-2 infection. As part of this study, the disease progression of these patients will be monitored. Study objective: Prospective, controlled follow-up observation of SARS-CoV-2 positive patients regarding their secondary diseases and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
526
Inclusion Criteria

A Inclusion Criteria of SARS-CoV-2 positive patients:

Patient must meet all of the following criteria.

  1. Positive test for SARS-CoV-2 by PCR
  2. Signed informed consent and privacy policy

B Inclusion Criteria of the control Group:

Volunteer must meet all of the following criteria.

  1. No contact to SARS-CoV-2 positive patients
  2. negative SARS-CoV-2 antibody test
  3. Signed informed consent and privacy policy
Exclusion Criteria

Patient/Volunteer will be excluded if any of the following conditions apply:

  1. Patient/Volunteer age < 18 years
  2. Patient/Volunteer who are unable to read the information and understand the nature of the study
  3. Patient/Volunteer participate in any other clinical study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of HospitalizationBetween 1 year after enrollment and 5 years after last patient in

Primary endpoint

Secondary Outcome Measures
NameTimeMethod
EQ-5D-5LBetween 1 year after enrollment and 5 years after last patient in

Secondary endpoint

KCCQ-12Between 1 year after enrollment and 5 years after last patient in

Secondary endpoint

Trial Locations

Locations (1)

Hegau-Bodensee-Klinikum Singen

🇩🇪

Singen, Baden-Württemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath